BHVN has 36-month beta value of 4.12. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BHVN is 76.29M, and currently, short sellers hold a 12.11% ratio of that float. The average trading volume of BHVN on June 26, 2024 was 1.35M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BHVN) stock’s latest price update
Biohaven Ltd (NYSE: BHVN)’s stock price has dropped by -1.66 in relation to previous closing price of 35.00. Nevertheless, the company has seen a gain of 5.04% in its stock price over the last five trading days. investors.com reported 2024-05-29 that Biohaven stock crashed Wednesday after the company’s experimental protein-degrading drug lagged investor expectations.
BHVN’s Market Performance
Biohaven Ltd (BHVN) has experienced a 5.04% rise in stock performance for the past week, with a -6.26% drop in the past month, and a -38.85% drop in the past quarter. The volatility ratio for the week is 4.85%, and the volatility levels for the past 30 days are at 6.65% for BHVN. The simple moving average for the last 20 days is 0.61% for BHVN’s stock, with a simple moving average of -10.34% for the last 200 days.
Analysts’ Opinion of BHVN
Many brokerage firms have already submitted their reports for BHVN stocks, with RBC Capital Mkts repeating the rating for BHVN by listing it as a “Outperform.” The predicted price for BHVN in the upcoming period, according to RBC Capital Mkts is $62 based on the research report published on February 16, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see BHVN reach a price target of $59. The rating they have provided for BHVN stocks is “Buy” according to the report published on February 06th, 2024.
H.C. Wainwright gave a rating of “Buy” to BHVN, setting the target price at $50 in the report published on December 22nd of the previous year.
BHVN Trading at -7.73% from the 50-Day Moving Average
After a stumble in the market that brought BHVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.67% of loss for the given period.
Volatility was left at 6.65%, however, over the last 30 days, the volatility rate increased by 4.85%, as shares sank -10.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.01% lower at present.
During the last 5 trading sessions, BHVN rose by +3.81%, which changed the moving average for the period of 200-days by +83.59% in comparison to the 20-day moving average, which settled at $34.02. In addition, Biohaven Ltd saw -19.58% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BHVN starting from Car Bruce, who purchase 30,000 shares at the price of $33.58 back on Jun 17 ’24. After this action, Car Bruce now owns 30,000 shares of Biohaven Ltd, valued at $1,007,490 using the latest closing price.
CHILDS JOHN W, the Director of Biohaven Ltd, purchase 28,000 shares at $35.58 during a trade that took place back on May 30 ’24, which means that CHILDS JOHN W is holding 2,311,341 shares at $996,240 based on the most recent closing price.
Stock Fundamentals for BHVN
The total capital return value is set at -1.63. Equity return is now at value -133.69, with -99.74 for asset returns.
Based on Biohaven Ltd (BHVN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -11.68.
Currently, EBITDA for the company is -432.68 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.03.
Conclusion
To put it simply, Biohaven Ltd (BHVN) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
